Erectile Dysfunction / Premature Ejaculation News
Latest Erectile Dysfunction / Premature Ejaculation News From Medical News Today.
Updated: 44 min 45 sec ago
Pivotal Study For PSD502--The First Potential Treatment For Premature Ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Results of the double-blind treatment phase of this study, which enrolled patients from the U.S.
Categories: Men's Health News
Zydena Is Efficacious In Once Daily Dosing For Erectile Dysfunction/Positive BPH Results
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED). The multi-center study conducted in Korea was a randomized, double-blind, placebo-controlled study, designed to investigate the efficacy and safety of udenafil in patients with ED.
Categories: Men's Health News
Risk Of Male Sexual Dysfunction Increases Following Workplace BPA Exposure
High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in the journal Human Reproduction, published by Oxford Journals. [1] The five-year study examined 634 workers in factories in China, comparing workers in BPA manufacturing facilities with a control group of workers in factories where no BPA was present.
Categories: Men's Health News
Growing Animal Penile Erectile Tissue In Lab May Benefit Patients
In an advance that could one day enable surgeons to reconstruct and restore function to damaged or diseased penile tissue in humans, researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine have used tissue engineering techniques to completely replace penile erectile tissue in animals. In the online early edition (Nov.
Categories: Men's Health News
Drug Shows Promise In Treating Dangerous Complication Of Erectile Disorder
Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston. Priapism is a condition of persistent painful penile erection in the absence of sexual desire. It is highly associated with sickle cell disease, leukemia and other blood disorders.
Categories: Men's Health News
For Patients With Erectile Dysfunction (ED) , Treatment With Oral Medications Demonstrates Significant Improvements In Sexual Intercourse And ED
The American College of Physicians (ACP) has issued recommendations for the treatment of erectile dysfunction (ED). ACP, the nation's largest medical specialty organization and second-largest physician group, strongly recommends that physicians initiate therapy with an oral phosphodiesterase type 5 (PDE-5) inhibitor in men who seek treatment for ED unless they have a contraindication to PDE-5 inhibitors, such as nitrate therapy.
Categories: Men's Health News
Minimally Invasive Radical Prostatectomy Shows Some Advantages, But Also Higher Rate Of Certain Complications
New research indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy, which have increased significantly in recent years, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.
Categories: Men's Health News
ESAI Provides Grant To LA BioMed To Investigate Long-Term Correction Of Erectile Dysfunction
Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV.
Categories: Men's Health News
Potential Relationship Between Androgen Deficiency And Cardiovascular Disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD). These findings appear in the September/October issue of the Journal of Andrology.
Categories: Men's Health News
35,000 Pounds Of Unlicensed Medicine Found In Car Boot
More than £35,000 of unlicensed erectile dysfunction medicine was seized in Sutton Coldfield yesterday as part of a covert investigation undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA). A 60-year-old man was arrested for possession with intent to supply the medicines which included Kamagra, Savitra and Apcalis, all unlicensed Indian products.
Categories: Men's Health News
Topical Erectile Dysfunction Therapy Shows Promise
An innovative drug-delivery system nanoparticles encapsulating nitric oxide or prescription drugs shows promise for topical treatment of erectile dysfunction (ED), according to a new study by scientists at Albert Einstein College of Medicine of Yeshiva University. The new system, tested successfully on a small number of animals, could potentially prevent side effects associated with oral ED medications, if study results can be replicated in humans.
Categories: Men's Health News
Concerns Raised About 'Telemedicine' Approach To Erectile Dysfunction, Australia
The Royal Australian College of General Practitioners (RACGP) has voiced concerns about the prescribing practices of erectile dysfunction clinics currently under review by the House of Representatives Standing Committee on Health and Ageing, Roundtable on Impotency Treatments. "Of the greatest concern is the use of telemedicine to treat erectile dysfunction," said Dr Chris Mitchell, RACGP President and GP in Northern NSW .
Categories: Men's Health News
Obesity And Weight Management Explores Link Between Erectile Dysfunction And Obesity
Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Inc. The article is available free online at http://www.liebertpub.
Categories: Men's Health News
Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile With Subcutaneous Administration
Palatin Technologies, Inc. (NYSE Amex: PTN) announced the completion of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without blood pressure side effects.
Categories: Men's Health News
Erectile Aid Use By Men Treated For Localized Prostate Cancer
UroToday.com - A UCLA single-institution study in the online edition of the Journal of Urology reports on the use of erectile aid (EA) following treatment for localized prostate cancer (CaP). Participants with a diagnosis of CaP were prospectively recruited between 1999 and 2003. Clinical and pathological data was abstracted and HRQOL (Health Related Quality of Life) outcomes were prospectively abstracted at baseline and 1, 2, 4, 8, 12, 18, 24, 30, 36, 42 and 48 months.
Categories: Men's Health News
Oncological Results, Functional Outcomes, Quality-of-Life - Radical Prostatectomy Or External Beam Radiation Therapy For Localized Prostate Cancer
UroToday.com - Most recently, health-related quality-of-life (HRQOL) after definitive local therapy for prostate cancer has been argued in the patient group with an oncological risk category.
Categories: Men's Health News
